Clin2
NCT06778616Possibly a fitNot yet recruiting

Predicting repeat belly fluid infections in cirrhosis patients

Spontaneous Bacterial Peritonitis

Part of Digestive system, Infections clinical trials.

This study looks at patients with cirrhosis who have had a first infection in the belly fluid (called SBP). The goal is to find out how often this infection returns and what factors might predict it coming back.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
101 people
Ages
Up to 80 years
Study type
Observational

Who can take part

  • You are at least 18 years old.
  • You have been diagnosed with cirrhosis (a type of liver disease).
  • You have had at least one episode of SBP (an infection in the fluid around your belly).
  • Your diagnosis of SBP was based on a specific cell count in the fluid around your belly.
  • You do not have other infections or conditions that could be confused with SBP.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07116369Not yet recruiting
Predicting belly fluid infection in cirrhosis using simple blood tests

This study looks at whether simple blood tests (platelet count, sodium level, and a new index called ALBI) can help predict a serious infection in the belly fluid (spontaneous bacterial peritonitis) in people with cirrhosis and ascites.

Sohag
NCT07024355Not yet recruiting
Predicting infection in cirrhosis patients with ascites

This study tests a new scoring system to predict if patients with liver cirrhosis and ascites (fluid in the belly) will develop a serious infection called spontaneous bacterial peritonitis. It aims to help doctors identify high-risk patients earlier so they can be monitored more closely.

NCT06679842Not yet recruiting
Early fluid removal for infected belly fluid

This trial tests whether removing infected fluid from the belly early helps people with cirrhosis and an infection called SBP. It may reduce the chance of complications and improve recovery.

Besançon, Doubs
NCT04161768Recruiting· Phase 3
Antibiotic pill study to prevent repeat belly infection in liver disease

This study tests whether taking norfloxacin plus itopride helps prevent another episode of spontaneous bacterial peritonitis (a serious belly infection) in people with cirrhosis and fluid buildup in the abdomen. It compares that combo to norfloxacin alone to see which approach better lowers repeat infections.

Tanta
NCT06884306Not yet recruiting
Predicting belly infection in cirrhosis patients

This study looks at ways to predict a serious infection in the belly fluid (called spontaneous bacterial peritonitis) that can happen in people with cirrhosis. It aims to find easy markers to catch this infection early and help guide treatment.

NCT06995846Enrolling by invitation
Testing bacterial DNA in belly fluid to diagnose SBP in cirrhosis

This study tests a new way to detect bacteria in the fluid in your belly (ascites) to see if it can quickly diagnose a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis. If you have cirrhosis and ascites, this trial may help improve how fast infections are found.

Beijing

Hear when a new Spontaneous Bacterial Peritonitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.